IP Library Granted Patent US 7,960,099
Granted Patent B2
US 7,960,099 · App. 11/967,897 · Granted Jun 14, 2011

White blood cell differentiation reagent containing an asymmetric cyanine fluorescent dye and method of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,099
App. No.
11/967,897
Granted
Jun 14, 2011
Kind
B2
Abstract

The present disclosure provides a white blood cell differentiation reagent comprising a fluorescent dye compound of Formula I, wherein R 1 , R 2 , R 3 , R 4 , Y − and n are as defined in the specification. The present disclosure also provides a white blood cell detection kit comprising the white blood cell differentiation reagent, and a method of differentiating white blood cells using the white blood cell differentiation reagent.

Claims (33)

1. A white blood cell differentiation reagent, comprising a fluorescent dye compound having the following Formula I:

wherein R 1 , R 2 , R 3 and R 4 are independently selected from the following: H, C 1-20 alkyl, C 2-20 alkenyl and C 2-20 alkynyl, n is 1, 2 or 3, and Y − is an anion.

2. The white blood cell differentiation reagent according to claim 1 , wherein the fluorescent dye compound has the following Formula II:

3. The white blood cell differentiation reagent according to claim 1 , wherein the fluorescent dye compound is present in a concentration of between 1 mg/L to 1,000 mg/L.

4. The white blood cell differentiation reagent according to claim 3 , wherein the fluorescent dye compound has the following Formula II:

5. The white blood cell differentiation reagent according to claim 1 , wherein the fluorescent dye compound is present in a concentration of between 2 mg/L to 100 mg/L.

6. The white blood cell differentiation reagent according to claim 1 , wherein the fluorescent dye compound is present in a concentration of between 5 mg/L to 50 mg/L.

7. The white blood cell differentiation reagent according to claim 1 , wherein the fluorescent dye compound is present in a concentration of between 10 mg/L to 20 mg/L.

8. The white blood cell differentiation reagent according to claim 1 , wherein the reagent further comprises a red blood cell lysing agent.

9. The white blood cell differentiation reagent according to claim 8 , wherein the red blood cell lysing agent comprises at least one of the following: a cationic surfactant, a nonionic surfactant, a buffer or any combination thereof.

10. The white blood differentiation reagent according to claim 9 , wherein the red blood cell lysing agent comprises a cationic surfactant selected from: octyltrimethyl ammonium bromide (OTAB), decyltrimethyl ammonium bromide (DTAB), lauryltrimethyl ammonium chloride (LTAC), cetyl trimethyl ammonium bromide (CTAB), or cetyl trimethyl ammonium chloride (CTAC) or mixtures thereof.

11. The white blood differentiation reagent according to claim 10 , wherein the cationic surfactant comprises LTAC at a concentration of between 300 and 800 mg/L.

12. The white blood differentiation reagent according to claim 9 , wherein the red blood cell lysing agent comprises a nonionic surfactant selected from: long chain fatty alcohol polyoxyethylene ether, alkylphenol polyoxyethylene ether, fatty acid polyoxyethylene ester, fatty amine polyoxyethylene ether or mixtures thereof.

13. The white blood differentiation reagent according to claim 12 , wherein the nonionic surfactant comprises polyoxyethylene (23) lauryl ether (Brij 35) at a concentration of between 1 and 5 g/L.

14. The white blood differentiation reagent according to claim 9 , wherein the red blood cell lysing agent comprises a buffer selected from: carboxylate salts, phosphate salts, citrate salts, Tris-HCl, MOPS or mixtures thereof.

15. The white blood differentiation reagent according to claim 14 , wherein the buffer is selected from: Tris-HCl or MOPS.

16. The white blood differentiation reagent according to claim 14 , wherein the buffer is configured to maintain a pH of a detection system at between 7.0 and 8.0.

17. The white blood differentiation reagent according to claim 9 , wherein the red blood cell lysing agent further comprises an alcohol.

18. The white blood cell differentiation reagent according to claim 9 , wherein the fluorescent dye compound is present in the form of a single stock solution.

19. The white blood cell differentiation reagent according to claim 1 , wherein the fluorescent dye compound is present in the form of a single stock solution.

20. A white blood cell detection kit comprising the white blood cell differentiation reagent according to claim 1 .

21. The detection kit according to claim 20 , wherein the white blood cell differentiation reagent comprises a fluorescent dye compound having the following Formula II:

22. The detection kit according to claim 20 , wherein the fluorescent dye compound of the white blood cell differentiation reagent is present in the form of a single stock solution.

23. A method for differentiation of white blood cells in a blood sample, comprising:

(i) mixing the blood sample with a solution of a red blood cell lysing agent;

(ii) adding a solution of a fluorescent dye compound of Formula I to the blood sample:

wherein R 1 , R 2 , R 3 , R 4 , Y − and n are as defined in claim 1 ;

(iii) measuring at least one kind of scattered light parameters and at least one kind of fluorescence parameters of the resulting mixture of step ii; and

(iv) differentiating and/or counting the white blood cells according to the at least one kind of scattered light parameters and fluorescence parameters.

24. The method according to claim 23 , wherein the fluorescent dye compound has the following Formula II:

25. The method according to claim 23 , wherein adding the solution of fluorescent dye compound comprises adding the solution of the red blood cell lysing agent and the solution of the fluorescent dye compound to the sample simultaneously.

26. The method according to claim 25 , wherein the fluorescent dye compound has the following Formula II:

27. The method according to claim 23 , wherein adding the solution of fluorescent dye compound comprises adding the fluorescent dye compound to the blood sample subsequent to mixing the blood sample with the solution of the red blood cell lysing agent.

Assignments (3)
ASSIGNMENT OF FIFTY PERCENT (50%) OF THE ASSIGNOR ENTIRE RIGHT Recorded Nov 18, 2019
From: SHENZHEN MINDRAY SCIENTIFIC CO., LTD.
To: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Reel/Frame 051050/0276 →
ASSIGNMENT OF 50% OF THE ASSIGNOR ENTIRE RIGHT Recorded Jul 25, 2018
From: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
To: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.; SHENZHEN MINDRAY SCIENTIFIC CO., LTD.
Reel/Frame 046624/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2007
From: XU, BING; ZHANG, BAOHUA; KUANG, YUJI
To: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Reel/Frame 020305/0030 →